LONDON, GREATER LONDON, UNITED KINGDOM, May 9, 2025 /EINPresswire.com/ -- How Big Is the Cryptococcosis Market and How Fast Is It Growing? The global cryptococcosis market is experiencing robust ...

The annual general meeting 2025 (the "AGM") of Xbrane Biopharma AB ("Xbrane" or the "Company") was held today on 5 May 2025 and the following resolutions were passed by the meeting. Adoption of ...

Matinas BioPharma (NYSE:MTNB) Holdings, Inc. (NYSE American:MTNB), a pharmaceutical company with a market capitalization of $3.1 million and currently trading at $0.61 per share, announced on Monday ...

Now it’s at $568, and that’s after 6.87% beating today. Regeneron is arguably the most innovative biopharma company I’ve seen in the last two decades. But the stock’s come in significantly ...

CHICAGO--(BUSINESS WIRE)--Xeris Biopharma Holdings, Inc. (Nasdaq: XERS), a growth-oriented biopharmaceutical company committed to improving patient lives by developing and commercializing ...

A biopharmaceutical company in Hinjewadi fell victim to a ransomware attack, with cybercriminals demanding $80,000 for the release of encrypted data. The Pimpri Chinchwad police are investigating ...

Biopharma venture funding dropped 20% in the first quarter of 2025 compared to the same period the year before, according to GlobalData. Worldwide venture financing for the sector experienced a ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...